[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Chahoud et al., 2022 - Google Patents

Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up

Chahoud et al., 2022

View HTML
Document ID
3170736628245841756
Author
Chahoud J
Zacharias N
Pham R
Qiao W
Guo M
Lu X
Alaniz A
Segarra L
Martinez-Ferrer M
Gleber-Netto F
Pickering C
Rao P
Pettaway C
Publication year
Publication venue
Cancers

External Links

Snippet

Simple Summary Penile Squamous Cell Carcinoma (PSCC) is a rare but aggressive cancer and approximately 30–50% of cases are associated with high risk human papillomavirus (HR-HPV). HR-HPV infection has been shown to correlate with expression of protein …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/01Social networking
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means

Similar Documents

Publication Publication Date Title
Inamura Update on immunohistochemistry for the diagnosis of lung cancer
Chahoud et al. Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up
Kühn et al. HPV status as prognostic biomarker in head and neck cancer—which method fits the best for outcome prediction?
Wendt et al. Long-term survival and recurrence in oropharyngeal squamous cell carcinoma in relation to subsites, HPV, and p16-status
Hermida-Prado et al. Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients
Sheppard et al. Lymph node yield and ratio in selective and modified radical neck dissection in head and neck cancer—impact on oncological outcome
Idel et al. EVI1 as a Marker for Lymph Node Metastasis in HNSCC
Niu et al. NR2F6 expression correlates with pelvic lymph node metastasis and poor prognosis in early-stage cervical cancer
Van Bockstal et al. Interobserver agreement of PD-L1/SP142 immunohistochemistry and tumor-infiltrating lymphocytes (TILs) in distant metastases of triple-negative breast cancer: a proof-of-concept study. A report on behalf of the International Immuno-Oncology Biomarker Working Group
Cass et al. Automated quantitative analysis of p53, Cyclin D1, Ki67 and pERK expression in breast carcinoma does not differ from expert pathologist scoring and correlates with clinico-pathological characteristics
Ivković et al. Role of matrix metalloproteinases and their inhibitors in locally invasive papillary thyroid cancer
Parosanu et al. The prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma
Ko et al. Overexpression of LGR-5 as a predictor of poor outcome in patients with hepatocellular carcinoma
Tagliabue et al. Prevalence of central compartment lymph node metastases in papillary thyroid micro-carcinoma: A retrospective evaluation of predictive preoperative features
Susini et al. Immunohistochemical evaluation of FGD3 expression: A new strong prognostic factor in invasive breast cancer
Pinheiro et al. Incidental node metastasis as an independent factor of worse disease-free survival in patients with papillary thyroid carcinoma
Pizzimenti et al. BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category
Troiano et al. Immunohistochemical analysis revealed a correlation between Musashi-2 and Cyclin-D1 expression in patients with oral squamous cells carcinoma
Angelico et al. Evaluation of beta-catenin subcellular localization and water channel protein AQP1 expression as predictive markers of chemo-resistance in ovarian high-grade serous carcinoma: comparative study between preoperative peritoneal biopsies and surgical samples
Babiker et al. Clinicopathologic aspects of squamous cell carcinoma of the uterine cervix: role of PTEN, BCL2 and P53
Kawai et al. Melanoma inhibitory activity and melanoma inhibitory activity 2 as novel immunohistochemical markers of oral epithelial dysplasia
Montes-Mojarro et al. Multiparametric classification of non-muscle invasive papillary urothelial neoplasms: combining morphological, phenotypical, and molecular features for improved risk stratification
Forsare et al. The prognostic role of intratumoral stromal content in lobular breast cancer
Sjöblom et al. Tumor-associated trypsin inhibitor (TATI) as a biomarker of poor prognosis in oropharyngeal squamous cell carcinoma irrespective of HPV status
Muroni et al. Prognostic impact of membranous/nuclear epidermal growth factor receptor localization in clear cell renal cell carcinoma